MJ

Mohamedali Jawhar

Active Director Director DIN 10846891
DIN 10846891 First appointment Nov 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohamedali Jawhar

Data last updated:

Mohamedali Jawhar is a Director at Carnelian Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10846891
Primary Designation Director
Industry Pharma
First Appointment 22 Nov 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Nov 20242024Active

Board colleagues of Mohamedali Jawhar

NameDINCompanyDesignation
Ashker10846890Carnelian Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Carnelian Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mohamedali Jawhar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohamedali Jawhar

Mohamedali Jawhar currently holds 1 directorship: Carnelian Pharmaceuticals Private Limited (Director, since 22 Nov 2024).

Mohamedali Jawhar was first appointed on 22 Nov 2024 as Director at Carnelian Pharmaceuticals Private Limited.

The current boards of Mohamedali Jawhar's companies include Ashker (Carnelian Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available